O médico disse que estou com Urticária Auto Alérgica por ter problema na tireoide — O que é isso?
The manifestations associated with Urticaria These issues raise important clinical questions and require specialized guidance to avoid the risks of self-medication or unnecessary restrictions. When addressing the topic "O médico disse que estou com Urticária Auto Alérgica por ter problema na tireoide — O que é isso?"This educational guide brings together the practical knowledge of the medical team from the Brazil Without Allergies Project in order to clarify the triggering factors, the most accurate diagnostic tests, and the modern therapeutic strategies currently available.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Entendendo a Urticária Autoalérgica e sua Relação com Doenças da Tireoide
A urticária crônica é uma condição dermatológica complexa e desafiadora, frequentemente dividida em diferentes subtipos para direcionar a melhor conduta terapêutica. Entre as suas principais classificações, destacam-se a urticária crônica induzida — desencadeada por fatores externos como frio, calor, vibração ou estresse — e a urticária crônica espontânea. Quando nos concentramos na modalidade espontânea, o quadro pode se subdividir em formas alérgica, autoalérgica e autoimune.
Para compreender o diagnóstico de urticária autoalérgica associada a problemas na tireoide, é fundamental entender como o sistema imunológico reage. Na urticária alérgica tradicional, o organismo produz anticorpos da classe IgE voltados contra proteínas estranhas ao corpo, como ácaros da poeira domiciliar, fungos ou mofo. Em contrapartida, na urticária crônica autoalérgica, ocorre a produção de anticorpos IgE direcionados contra proteínas do próprio organismo.
Muitas vezes, essa resposta imunológica está relacionada a alterações na glândula tireoide. Nesses casos, a investigação médica costuma analisar a presença de autoanticorpos específicos, como os anticorpos anti-tireoperoxidase e anti-tireoglobulina:
- Urticária autoalérgica: Envolve a produção de anticorpos da classe IgE específicos contra estruturas ou proteínas próprias, podendo incluir componentes da tireoide.
- Urticária autoimune: Caracteriza-se pela presença de autoanticorpos de outras classes que também podem interagir com os mastócitos — células de defesa ricas em histamina.
É perfeitamente possível que um paciente apresente simultaneamente componentes autoalérgicos e autoimunes. Quando esses autoanticorpos se ligam aos receptores de alta afinidade presentes na superfície dos mastócitos, estimulam a liberação de histamina e outras substâncias inflamatórias, resultando no surgimiento das temidas lesões avermelhadas e pruriginosas na pele.
O manejo terapêutico da urticária crônica associada a distúrbios da tireoide exige uma avaliação médica minuciosa e individualizada. Em algumas situações, o uso isolado de anti-histamínicos pode não conferir o alívio adequado dos sintomas, enquanto o uso prolongado de corticosteroides deve ser evitado devido aos efeitos colaterais sistêmicos. Nesses cenários mais refratários, o uso de terapias avançadas, como anticorpos monoclonais (a exemplo do omalizumabe), pode ser avaliado pelo especialista. Este medicamento atua bloqueando os receptores e impedindo a ativação dos mastócitos, oferecendo uma nova perspectiva de controle para os pacientes.
Este conteúdo possui caráter estritamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e a avaliação individualizada com um médico especialista em Alergia e Imunologia.
Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema
In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.
💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management
Mast Cell Activation, Histamine, and the Bradykinin Pathway
When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.
Therapeutic Escalation without Overuse of Corticosteroids
As diretrizes internacionais preconizam os anti-histamínicos H1 de segunda geração (não sedativos) em doses otimizadas sob supervisão médica como primeira linha, reservando anticorpos monoclonais anti-IgE (como o omalizumabe) para casos crônicos refratários e evitando ciclos repetidos de corticoides sistêmicos que causam efeito rebote. A investigação com allergy test e avaliação especializada de pele permite excluir gatilhos ocultos e alinhar, quando há atopia coexistente, estratégias como a allergy vaccine.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Eixo Inflamatório Th1/Th17, Gatilhos Ambientais e Barreira Epidérmica
Na interface entre a Imunologia Clínica, a Dermatologia e a Reumatologia, avaliar o paciente de forma sistêmica permite reconhecer precocemente comorbidades metabólicas, articulares e eventuais hipersensibilidades coexistentes. Exames como o Fator Antinuclear (FAN) e provas inflamatórias atuam como ferramentas de triagem que só adquirem significado diagnóstico real quando interpretados à luz do exame físico detalhado da pele, unhas, couro cabeludo e articulações.
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. For peaceful skin, free from constant itching and sleep-depriving flare-ups.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to Urticaria It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. rhinitis treatment Whenever indicated — ensures clinical safety and long-lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




